Kristopher Dennis

EUS-guided platinum seed fiducials implanted in liver for SABR. Fluoroscopic view during EUS-guided implantation (A), non-contrast CT 7 days post-implantation (B), MRI 7 days post-implantation (C), Cyberknife® SABR treatment planning with target localization (D).

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

2. Materials and Methods This is a single-institution, ethics approved, retrospective study carried out at a large Canadian cancer center, the main treatment facility for approximately1.4 million people. Electronic records were reviewed for all patients who received SBRT to the pancreas on a CyberKnife robotic radiosurgery unit (Accuray Incorporated., Sunnyvale, CA, USA) from September 2010 to January 2021.